Adora Ndu

Adora Ndu has served as a member of DBV’s Board of Directors since 2021. Dr. Ndu is currently the Group Vice President, Head of Worldwide Research and Development Strategy, Scientific Collaborations and Policy at BioMarin Pharmaceutical. She brings over 15 years of complementary experience in drug development and regulatory affairs. Her expertise incorporates regulatory strategy, patient engagement, prescription drug promotion, and policy for U.S. and international markets. Prior to joining BioMarin, Dr. Ndu was Director and Head of the Division of Medical Policy Development at the U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research and also a Commander in the Commissioned Corps, U.S. Public Health Service. She has been involved in the registrations of multiple products globally and is a respected thought leader in regulatory science, having played a significant role in developing and evaluating guidance, as well as shaping regulatory policy. Dr. Ndu received her doctorate in pharmacy from Howard University’s College of Pharmacy and a law degree from the University of Maryland.